Accueil   Diary - News   All news PDC*line Pharma welcomes Dr Channa Debruyne to its management team

PDC*line Pharma welcomes Dr Channa Debruyne to its management team

 

With more than 25 years experience in chemotherapeutic products and cancer vaccines, she will lead the ongoing phase I/II trial in NSCLC

 

Liège, Belgium, and Grenoble, France, September 9, 2019 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today that Dr Channa Debruyne joined the company in August as medical director, to lead the clinical research team.

 

Read the press release